Skip to main content
. 2015 Jul 13;45(3):683–692. doi: 10.1093/ije/dyv118

Table 1.

Baseline characteristics of ProF-SC participants, by breast cancer status at baseline and by loss to follow-up

Total cohort ( n  = 31640)
Affected at baseline ( n  = 12787)
Unaffected at baseline ( n  = 18853)
Lost to follow-up ( n  = 5728) a
N or % or mean ± SD (min, max) N or % or mean ± SD (min, max) N or % or mean ± SD (min, max) N or % or mean ± SD (min, max)
BRCA1 mutation only 1514 782 732 174
BRCA2 mutation only 1219 633 586 138
BRCA1 & BRCA2 mutation 8 8 0 1
Year at recruitment
 1992–94 1.7 1.1 2.0 0.6
 1995–99 47.1 47.8 46.6 38.0
 2000_04 30.2 29.8 30.5 35.0
 2005–09 18.3 17.9 18.6 23.3
 2010–30 June 2011 2.7 3.3 2.3 3.1
Age at baseline (years) 49.8 ± 14.8 52.9 ± 12.1 47.8 ± 16.1 48.8 ± 15.5
(18, 101) (21, 98) (18, 101) (18, 97)
Number of first-degree relatives with breast cancer 0.9 ± 0.8 0.6 ± 0.8 1.1 ± 0.7 0.9 ± 0.8
(0, 6) (0, 6) (0, 6) (0, 6)
Number of second-degree relatives with breast cancer 0.7 ± 0.9 0.6 ± 0.9 0.8 ± 1.0 0.7 ± 0.9
(0, 11) (0, 8) (0, 11) (0, 7)
Body mass index (BMI) (kg/m 2 ) 25.9 ± 5.6 26.2 ± 5.6 25.8 ± 5.6 26.2 ± 5.8
Age at menarche (years) 12.8 ± 1.6 12.7 ± 1.6 12.9 ± 1.6 12.8 ± 1.6
Smoking status
 Never 60.1 59.4 60.5 61.1
 Former 26.9 28.3 25.9 23.3
 Current 13.1 12.3 13.7 15.6
Alcohol intake
 Never 52.4 54.4 51.1 58.7
 Former 14.3 13.4 14.9 14.1
 Current 33.3 32.3 34.0 27.2
Menopausal hormone use
 Never 75.1 72.8 76.7 79.6
 Former 16.9 24.5 11.8 13.9
 Current 7.9 2.7 11.5 6.5
Hormonal contraceptive use
 Never 27.5 29.1 26.4 33.5
 Former 64.1 69.3 60.5 58.5
 Current 8.4 1.6 13.0 8.0
Race/ethnicity
 Non-Hispanic White 75.9 68.8 80.8 62.7
 Non-Hispanic Black 6.2 8.6 4.6 8.7
 Hispanic 9.4 11.2 8.1 15.1
 Asian 5.8 8.8 3.8 10.2
 Other 2.7 2.7 2.7 3.3
Education
 ≤High school graduation / GED 34.4 34.6 34.3 40.4
 Vocational or technical school / some college or university 36.8 35.6 37.7 33.7
 Bachelor’s or graduate degree 28.7 29.8 28.0 26.0
Benign breast disease
 Yes 31.0 36.3 27.4 26.7
 No 69.0 63.7 72.6 73.3
Parity
 0 21.1 17.7 23.5 23.2
 1 11.7 13.0 10.8 13.3
 2 30.0 33.4 27.7 27.8
 3 20.3 20.5 20.2 17.8
 ≥4 16.8 15.5 17.7 17.9
Menopausal status
 Premenopausal 45.1 30.3 55.3 49.9
 Postmenopausal 54.9 69.7 44.7 50.1

a Includes refusals and not located.